PARMAR KUSH
Director
2 filings on record here, covering TRDA. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-10
| Sell | TRDA | Entrada Therapeutics, Inc. | $73,458 |
| Sell | TRDA | Entrada Therapeutics, Inc. | $358,371 |
| Sell | TRDA | Entrada Therapeutics, Inc. | $647,108 |
CORPORATEFiled 2026-08-03
| Sell | TRDA | Entrada Therapeutics, Inc. | $795,259 |
| Sell | TRDA | Entrada Therapeutics, Inc. | $11,768 |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.